Ankylosing spondylitis trials in United States
16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Where
- Albuquerque, Apple Valley, Baytown, Beckley, Bellevue, Chicago, Colleyville, Covina, Duncansville, Fort Collins, Fullerton, Jackson, Lansing, Mesquite, Murfreesboro, Ormond Beach, Peoria, Plano, Riverside, Rock Hill, San Leandro, South Miami, Spokane, Temecula, Upland, Vandalia, West Long Branch, Whittier, Zephyrhills
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07290036 - No phaseTaking peopleNatural History and Development of Spondyloarthritis
- Where
- Bethesda
- Age
- 2 years to 99 years
- People
- 2,000
- Run by
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
See details and how to joinNCT01422694 - No phaseTaking peopleRENEW Intervention for Axial Spondyloarthritis
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 40
- Run by
- University of Michigan
See details and how to joinNCT07836374 - Phase 2Taking peopleA Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
- Where
- Arlington, Aventura, Baltimore, Brandon, Chandler, Chicago, Chula Vista, Cooper City, Corpus Christi, Denver, Duncansville, Flagstaff, Fort Worth, Fullerton, Gilbert, Glendale, Houston, Huntington Beach, Irving, Kalispell, Kansas City, Lincoln, Murfreesboro, Palmetto Bay, Philadelphia, Portland, Red Oak, Rockville, Santa Fe, St Louis, The Woodlands, Thousand Oaks, Tomball, Tucson, Upland, Willowbrook
- Age
- 18 years to 80 years
- People
- 315 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07133633 · EU 2025-521059-21-00 - Phase 4Not yet taking people in United StatesA Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- The University of Texas Health Science Center, Houston
See details and how to joinNCT07770646 - Phase 1Taking peopleA Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Where
- Boston, Chapel Hill, Durham, Milwaukee, Santa Monica, South Miami
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00 - No phaseTaking peopleExactech Shoulder Post Market Clinical Follow-up Study
- Where
- Akron, Asheville, Augusta, Charleston, Denver, Detroit, Durham, Fort Collins, Franklin, Gainesville, Greenville, Jacksonville, Laguna Woods, New York, Palm Beach Gardens, Pewaukee, Redwood City, Rockford, Schaumburg, Stockton, Tampa, Virginia Beach, West Palm Beach
- Age
- 21 years and over
- People
- 20,000 worldwide
- Run by
- Exactech
See details and how to joinNCT05603728 - Phase 2Taking peopleImmunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Where
- New York
- Age
- 18 years and over
- People
- 80
- Run by
- NYU Langone Health
See details and how to joinNCT07138898 - No phaseTaking peoplePhysical Activity Through Health Technology in Axial Spondyloarthritis
- Where
- Seattle
- Age
- 18 years and over
- People
- 40
- Run by
- University of Washington
See details and how to joinNCT07642622 - No phaseTaking peopleTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Where
- Houston
- Age
- 18 years and over
- People
- 125
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04751396 - Phase 4Taking peopleA Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- Where
- Cleveland, Philadelphia, Portland
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00 - No phaseTaking peopleRheumatology Patient Registry and Biorepository
- Where
- New Haven
- Age
- 18 years to 99 years
- People
- 5,000
- Run by
- Yale University
See details and how to joinNCT04402086 - Phase 4Not yet taking people in United StatesImpact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT07018206 · EU 2025-522118-21-00 - No phaseTaking peopleUnhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Where
- Delafield
- Age
- 2 years and over
- People
- 10,000
- Run by
- Brain Inflammation Collaborative
See details and how to joinNCT04806620 - No phaseTaking peopleRheumatology Diet Study
- Where
- Orlando
- Age
- 18 years to 65 years
- People
- 500
- Run by
- University of Central Florida
See details and how to joinNCT06339957 - No phaseTaking peopleIMPACT - AndHealth Autoimmune Research Registry
- Where
- Columbus
- Age
- 18 years to 70 years
- People
- 2,500
- Run by
- AndHealth
See details and how to joinNCT05883371